Clinical Supply Regulatory Articles

1. Policy Is Redefining Clinical Trials. Clinical Supply Must Respond. 10/23/2026

   Clinical trial policy is shifting research closer to patients, creating new demands for forecasting, distribution, inventory, accountability, cold chain, and cross-functional planning.

2. Is Your Supply Chain Ready For The End Of Class VI? 10/21/2026

   Revisions to USP <87> and <88> update biological reactivity testing — changes that are especially important for companies that rely on single-use technology.

3. Clinical Trial Supply In The EU And U.K.: A Regulatory Guide 10/20/2026

   EU and U.K. clinical trial rules are evolving separately. Here’s what sponsors need to consider across QP release, labeling, importation, and supply continuity.

4. When Drug Supply Has A Half-Life: Radiopharmaceutical Logistics 10/1/2026

   Radiopharmaceuticals turn time into a supply-chain constraint. Short half-lives, patient scheduling, scarce radionuclides and regulatory differences reshape trial logistics.

5. Segregation Of Duties: Drug Accountability Needs Three Separate Roles 9/28/2026

   When one person orders, receives, and reconciles investigational product, a critical control disappears. See how role separation can strengthen drug accountability.

6. Before The Excursion: The Governance Decisions That Should Already Be Made 9/24/2026

   Temperature excursions are inevitable. The real risk is the time lost deciding what to do. See how preplanned governance can turn long quarantines into routine events.

7. US Pharma Reshoring: The Full Policy Timeline 9/17/2026

   As policy shifts and manufacturing investments reshape pharma supply chains, capacity constraints and global dependencies persist. Explore the implications for long-term resilience.

8. The Reliance Trap: When Regulatory Strategy Becomes A Clinical Supply Problem 9/17/2026

   The wrong regulatory filing sequence can close faster pathways, delay importation, and consume shelf life. Here’s how regulatory strategy can reshape clinical supply.

9. CSM Feasibility Begins With Research Strategy And Study Design 9/15/2026

   Study design decisions can create costly clinical supply problems months later. Early CSM review can expose hidden requirements before they become delays, waste, and rework.

10. Clinical Supply Systems Need IT General Controls 9/14/2026

    Validating a clinical trial system does not prove it stays trustworthy. IT general controls can protect data, supply decisions and patient safety long after go-live.